Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery
Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04815642
Collaborator
(none)
50
16
Study Details
Study Description
Brief Summary
This is a retrospective study on evaluation of the efficacy and the safety of a hypofractionated radiotherapy course with weekly concomitant boost for breast cancer patients treated with conservative breast surgery .
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
50 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Retrospective Study Evaluating Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery
Anticipated Study Start Date
:
Dec 1, 2021
Anticipated Primary Completion Date
:
Jan 1, 2023
Anticipated Study Completion Date
:
Apr 1, 2023
Outcome Measures
Primary Outcome Measures
- Disease free survival [baseline]
Disease Free survival
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
women aged from 18 and up to 55 years old.
-
Histologically diagnosed with breast carcinoma (ductal and others )
-
All patients with conservative breast surgery.
-
Including all patients with in all stages except those stage IV.
-
All patients with clear free surgical margin.
-
patients received hypofractionated radiotherapy with weekly concomitant boost
Exclusion Criteria:
-
Evidence of distant metastatic deposites.
-
patients with mastectomy
-
patients with prior irradiation to thoracic region.
-
pregnancy or lactation.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Assiut University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
Responsible Party:
Nada mohamed shawky,
Principal investigator,
Assiut University
ClinicalTrials.gov Identifier:
NCT04815642
Other Study ID Numbers:
- Radiation in breast cancer
First Posted:
Mar 25, 2021
Last Update Posted:
Aug 3, 2021
Last Verified:
Mar 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: